Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Statin wars: the heavyweight match--atorvastatin versus rosuvastatin for the treatment of atherosclerosis, heart failure, and chronic kidney disease.

DiNicolantonio JJ, Lavie CJ, Serebruany VL, O'Keefe JH.

Postgrad Med. 2013 Jan;125(1):7-16. doi: 10.3810/pgm.2013.01.2620. Review.

PMID:
23391667
2.

FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair.

Zhou W, Otto EA, Cluckey A, Airik R, Hurd TW, Chaki M, Diaz K, Lach FP, Bennett GR, Gee HY, Ghosh AK, Natarajan S, Thongthip S, Veturi U, Allen SJ, Janssen S, Ramaswami G, Dixon J, Burkhalter F, Spoendlin M, Moch H, Mihatsch MJ, Verine J, Reade R, Soliman H, Godin M, Kiss D, Monga G, Mazzucco G, Amann K, Artunc F, Newland RC, Wiech T, Zschiedrich S, Huber TB, Friedl A, Slaats GG, Joles JA, Goldschmeding R, Washburn J, Giles RH, Levy S, Smogorzewska A, Hildebrandt F.

Nat Genet. 2012 Jul 8;44(8):910-5. doi: 10.1038/ng.2347.

4.

A predictive model for progression of chronic kidney disease to kidney failure.

Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS.

JAMA. 2011 Apr 20;305(15):1553-9. doi: 10.1001/jama.2011.451. Epub 2011 Apr 11.

PMID:
21482743
5.

Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation.

[No authors listed]

Am J Kidney Dis. 2000 Jun;35(6 Suppl 2):S1-140. No abstract available. Erratum in: Am J Kidney Dis 2001 Oct;38(4):917.

PMID:
10895784
7.

Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials.

Wali RK, Iyengar M, Beck GJ, Chartyan DM, Chonchol M, Lukas MA, Cooper C, Himmelfarb J, Weir MR, Berl T, Henrich WL, Cheung AK.

Circ Heart Fail. 2011 Jan;4(1):18-26. doi: 10.1161/CIRCHEARTFAILURE.109.932558. Epub 2010 Oct 29.

8.
9.

Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure.

Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ, Kalantar-Zadeh K.

Circulation. 2012 Feb 7;125(5):677-84. doi: 10.1161/CIRCULATIONAHA.111.065391. Epub 2012 Jan 5.

10.

Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.

Iaina A, Silverberg DS, Wexler D.

Nat Clin Pract Cardiovasc Med. 2005 Feb;2(2):95-100. Review.

PMID:
16265380
11.

Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and cockroft-gault formulas.

Zamora E, Lupón J, Vila J, Urrutia A, de Antonio M, Sanz H, Grau M, Ara J, Bayés-Genís A.

J Am Coll Cardiol. 2012 May 8;59(19):1709-15. doi: 10.1016/j.jacc.2011.11.066.

12.

Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease.

Pitt B, Filippatos G, Gheorghiade M, Kober L, Krum H, Ponikowski P, Nowack C, Kolkhof P, Kim SY, Zannad F.

Eur J Heart Fail. 2012 Jun;14(6):668-75. doi: 10.1093/eurjhf/hfs061. Epub 2012 May 4.

13.

Medical nutrition therapy in chronic kidney failure: integrating clinical practice guidelines.

Beto JA, Bansal VK.

J Am Diet Assoc. 2004 Mar;104(3):404-9. Review.

PMID:
14993863
14.
15.
16.

Interrelationship between cardiac hypertrophy, heart failure, and chronic kidney disease: endoplasmic reticulum stress as a mediator of pathogenesis.

Dickhout JG, Carlisle RE, Austin RC.

Circ Res. 2011 Mar 4;108(5):629-42. doi: 10.1161/CIRCRESAHA.110.226803. Review.

17.

Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.

McAlister FA, Ezekowitz J, Tarantini L, Squire I, Komajda M, Bayes-Genis A, Gotsman I, Whalley G, Earle N, Poppe KK, Doughty RN; Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) Investigators.

Circ Heart Fail. 2012 May 1;5(3):309-14. doi: 10.1161/CIRCHEARTFAILURE.111.966242. Epub 2012 Mar 22.

18.

Novel criteria of urine osmolality effectively predict response to tolvaptan in decompensated heart failure patients--association between non-responders and chronic kidney disease.

Imamura T, Kinugawa K, Shiga T, Kato N, Muraoka H, Minatsuki S, Inaba T, Maki H, Hatano M, Yao A, Kyo S, Nagai R.

Circ J. 2013;77(2):397-404. Epub 2012 Nov 3.

19.

Peginesatide (Omontys) for anemia in chronic kidney failure.

[No authors listed]

Med Lett Drugs Ther. 2012 Jun 11;54(1392):45-6. No abstract available.

PMID:
22683926
20.

Echocardiographic changes following hemodialysis initiation in patients with advanced chronic kidney disease and symptomatic heart failure with reduced ejection fraction.

Ganda A, Weiner SD, Chudasama NL, Valeri AM, Jadoon A, Shimbo D, Radhakrishnan J.

Clin Nephrol. 2012 May;77(5):366-75.

PMID:
22551882

Supplemental Content

Support Center